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Summary 
Elevated levels of p56-Lck kinase activity were achieved in an interleukin 2  (IL-2)-dependent 
cloned cytolytic T  cell CTLL-2 through gene transfer approaches. CTLL-2-Lck cells remained 
dependent on IL-2 for growth and survival  in culture but  exhibited markedly elevated,  IL- 
2-independent cytolytic activity against a variety of tumor targets. This immune cell effector 
function was similar to the non-major histocompatibility complex-restricted cytolytic activity 
previously described for lymphokine activated killer (LAK) cells, and involved a cytolytic mechanism 
that was independent of protein synthesis in either the T cells or the tumor targets. Characterization 
of CTLL-2-Lck cells revealed markedly elevated levels of both the o~ (CDlla)  and 3  (CD18) 
chains of the cell adhesion molecule lymphocyte function-associated 1 (LFA-1)  and increased 
binding of these T  cells to a recombinant protein representing the extracellular domain of the 
LFA-ligand, intercellular adhesion molecule 1 (ICAM-1). Antibodies to CDlla partially abrogated 
cytolytic killing of tumor target cells by CTLL-2-Lck cells,  suggesting that the upregulation 
in LFA protein levels potentially accounts at least in part for the phenotype of these T  cells. 
Gene transfer-mediated elevations in p56-Lck kinase activity in an IL-3-dependent myeloid cell 
clone 32D.3  also resulted in increased LFA-1 expression, demonstrating that the findings are 
not unique to CTLL-2 cells. In addition to upregulation of LFA-1 expression, CTLL-Lck cells 
also  exhibited  more  efficient exocytosis  of cytotoxic  granules  upon  activation  with  Ca  2+- 
ionophore and phorbol ester, relative to control transfected and untransfected CTLL2 cells. The 
findings functionally link the Lck kinase to a T  cell effector pathway involved in cell-mediated 
cytotoxicity. 
L 
k is a member of the Src family of nonreceptor protein 
tyrosine kinases (PTKs) 1 and is normally expressed ex- 
clusively in lymphocytes, primarily in T cells and NK cells 
(reviewed in 1). The p56-Lck FFK has been found in phys- 
ical association with the cytosolic domains a variety of cell 
surface receptors in T cells including CD2, CD4, CD8, and 
the 3 chain of the IL-2 receptor complex (2-6). Furthermore, 
triggering of most of these receptors with specific antibodies 
or ligands induces elevations in Lck kinase activity suggesting 
an important role for this PTK in some aspect of lymphocyte 
function. Though it is clear from investigations of klr knock- 
out mice that p56-Lck is critical for the thymic development 
of T  cells (7), knowledge of the functional significance of 
1Abbreviations used in  this paper: BLT, N-a-benzyloxycarbonyl-L-lysine 
thiobenzyl  ester; FI, fluorescence  intensity;  PTK, protein tyrosine  kinase; 
sICAM-1, soluble  intercellular  adhesion  molecule  1; TIA, T cell  intracellular 
antigen; TIL, tumor infiltrating lymphocytes. 
Lck kinase activation for the responses of mature, fully differen- 
tiated T  cells remains incomplete. 
In T  cell hybridomas, gene transfer-mediated elevations 
in  p56-Lck  kinase  activity have been  shown  to  augment 
production of the lymphokine IL-2 in response to certain T 
cell activation signals and in some cases can lead to constitu- 
tive IL-2 production (8, 9). In addition, a Lck-deficient mutant 
of the CD4 § T cell leukemia line Jurkat has been described 
that has several defects in TCK-initiated signal transduction, 
all of which are corrected by gene transfer-mediated restora- 
tion of p56-Lck production (10). These findings suggest that 
l_ck can regulate signal transduction pathways involved in TCK 
signal transduction and lymphokine gene expression under 
at least some circumstances. Consistent with this notion, T 
cells expressing mutants of CD4 that fail to bind to p56-Lck 
also are defective in IL-2 production when stimulated with 
antigen and antigen-presenting cells under conditions where 
MHC-class II interaction with CD4 is required for T  cell 
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role for Lck in regulating  at least one key event associated 
with  helper T  cell function,  namely IL-2 production. 
In cytolytic T  cells,  increases in p56-Lck kinase activity 
can be transiently  stimulated  by antibody-mediated  cross- 
linking of CD8 (2, 13). Furthermore, cytosolic domain mu- 
tants of CD8 that fail to associate with p56-Lck are defective 
in mediating signal transduction responses upon stimulation 
with alloantigen or anti-CD3-CD8 conjugate antibodies (14, 
15),  suggesting that  Lck plays an important  role in TCR- 
mediated responses at least under circumstances where co- 
stimulation through CD8 is also required. However, associ- 
ation of CD8 and p56-Lck does not appear to be essential 
for generation of allospecific CTL effector cells in vivo, nor 
for CTL-mediated  lysis  of allogenic cells  in vitro  (16). 
In addition to CD8, signaling through receptors for IL-2 
can also stimulate increases in p56-Lck kinase activity in cyto- 
lytic T cells, suggesting a role for Lck in some aspect of IL-2 
signal transduction in these cells (17, 18). Gene transfer studies 
using a constitutively active version ofp56-Lck (kbFS05) have 
demonstrated that high levels of Lck kinase activity can re- 
sult in IL-2-independent activation of phosphatidyl-inositol- 
3'-kinase,  but have no effect on IL-2 requirements  for cell 
proliferation,  growth,  and survival (18,  19).  Moreover, IL- 
2R-/8 mutants that fail to bind p56-Lck also fail to stimulate 
elevations in p56-Lck kinase activity in response to stimula- 
tion with IL-2 and are defective in induction of c-~s and c-jun 
mRNA  accumulation  but  not  in  stimulation  of cellular 
proliferation  (20).  These  observations  suggest  that  IL- 
2R-mediated activation of p56-Lck plays an important  role 
in some signal transduction pathways regulated by this lym- 
phokine, but not necessarily those involved in cell growth. 
Both CD8 and IL-2 have been shown to be capable of ei- 
ther directly or indirectly enhancing the cytolytic activity of 
killer T  cells,  raising the possibility of a functional connec- 
tion between p56-Lck and regulation of cell-mediated killing. 
Similarly,  stimulation  of NK cells  through  CD16 (FcR-y- 
IliA)  has  been shown to induce Lck kinase activation and 
trigger cytolytic responses by these immune cells (21), again 
suggesting a link between p56-Lck and cell-mediated cyto- 
toxicity. Indeed, studies of a variant subclone of the CD3 + / 
CD8 + T  cell CTLL-2 that  lacks p56-Lck revealed a defect 
in  cytolytic  effector  function  when  tested  in  antibody- 
redirected cytolysis assays using a hybridoma target cell that 
displays anti-CD3 monodonal antibodies on its surface (22). 
Furthermore,  gene  transfer-mediated  restoration  of  Lck 
production in these T cells was associated with markedly im- 
proved cytolytic effector function (22). Additional evidence 
implicating p56-Lck in cytolytic T  cell responses has come 
from Ick knock-out mice where the few T cells that survive 
the thymic selection process without Lck and reach the pe- 
riphery as mature T  cells have been shown to mount defec- 
tive CTL responses to viruses (23). The mechanism by which 
Lck might modulate signal transduction pathways involved 
in cytolytic activity however has not been previously addressed. 
Here we demonstrate  that  gene transfer-mediated  eleva- 
tions in p56-Lck kinase activity significantly enhance the cyto- 
lytic activity of CTLL-2 T  cells against tumor target cells. 
Furthermore,  the findings suggest that Lck upregulates cyto- 
lyric effector function through mechanisms that involve en- 
hanced adhesion  of T  cells  to target  cells and  more active 
exocytosis of cytotoxic granules.  These observations could 
have relevance to mechanisms of immune surveillance  against 
neoplasms, inasmuch as reductions in kb gene expression have 
been previously reported in the circulating T cells of animals 
with solid tumors (24),  and in the tumor-infiltrating  lym- 
phocytes (TIL) of patients  with renal carcinoma  (25). 
Materials and Methods 
Cells and Cell Culture.  CTLb2 and 32D.3 cell clones were main- 
tained in IL-2- or Ib3-containing culture media as described previ- 
ously (18, 26, 27). CTLL-N-LCK cells are a polyclonal population 
of G418-resistant cells that were transfected with an expression 
plasmid pGSE1731-LCK encoding  normal  human  p56-l_ck (18). 
CTLL-A-LCK is a clone of CTLL-2 cells that expresses at high levels 
a plasmid pCD2-MT-LCK(F505) encoding a routine p56-Lck ki- 
nase with a Tyr ---- Phe substitution  at position 505 (18, 28). The 
derivation and characterization of these kk-transfected CTLL-2 cells 
has been described in detail previously (18). CTLL-NEO is a ran- 
domly chosen clone of CTLL-2 cells that underwent  electropora- 
tion (900/~F; 750 V/cm) with 25/~g of NdeI-linearized pZIP-NEO 
plasmid DNA (29) and subsequent selection in medium containing 
IL2 and 400 #g/ml G418 (active concentration)  (GIBCO BILL, 
Gaithersburg, MD). 32D-NEO and 32D-LCK cells are polyclonal 
populations of G418-resistant 32D.3 cells that underwent electropo- 
ration (double pulse of 40/~F; 2,000 V/cm; 74 ohms followed by 
1,500 tzF; 250 V/cm; 74 ohms) with 25 #g of linearized pLXSN 
or pLXSN-Ick(FS05) plasmid DNA (9), respectively, followed by 
selection in media containing  Ib3 and m600/~g/ml active G418. 
Indirect Imrnunofluorescence  Assays.  Indirect  immunofluorescence 
detection and flow cytometric analysis of the cell surface antigens 
CD2, CD3, CD11a, CD18,  VLA-4, and NKI.1  was performed 
as described previously (30) using a FACScan Plus (Becton Dick- 
inson & Co., Mountain View, CA) and the following monoclonal 
antibodies, most of which were obtained either generously provided 
by  James Ryan (University of California at San Francisco, San Fran- 
cisco, CA [UCSF]) or from the American Type Culture Collection 
(ATCC; RockviUe, MD): RM2-5 (rat IgG2b;  CD2);  145-2Cll 
(hamster IgG;  CD3-e);  PK136 (mouse IgG2a; NKI.1);  FD4.4.1 
(rat IgG2b; CD11a); M18.5 (rat IgG2b; CD18), PS/2 (rat IgG2a; 
VLA-4);  M17/4.4.11.9  (rat  IgG2a;  CD11a), M18/2.a.12.7  (rat 
IgG2a; CD18). Negative control rat IgG2a, rat IgG 2b, and mouse 
IgG2b monoclonal antibodies were obtained from Coulter Immu- 
nology,  Inc. (Hialeah, FL).  Fluorescein-conjugated  antisera to 
mouse,  rat,  or hamster  IgG were purchased  from TAGO,  Inc. 
(Burlingame,  CA). 
Cytolytic Assays.  SlCr  release assays were performed essentially 
:as described by Wunderlich and Schearer (31). Briefly, 2-6  x  106 
target cells were labeled with 150 #Ci 51Cr in ~0.4 ml of com- 
plete medium (RPMI with 10% FCS, 1 mM t-glutamine, 100 U/ml 
penicillin, and 50/zg/ml  streptomycin) for 1.5 h at 37~  then 
washed 3x  with HBSS (GIBCO BRL) and resuspended in 1 ml 
of complete medium for 0.5 h at room temperature  to allow for 
spontaneous release before washing once with complete medium 
and resuspending at 10  s cells/ml. T cells were stripped of IL-2 by 
incubation  for 0.5-1  min in 1 ml of 10 mM sodium-citrate (pH 
4.0)/140 mM NaC1, followed immediately by dilution into 50 ml 
of HBSS. After two additional  washes in  HBSS, T  cells were 
resuspended in complete medium at 106 cells/ml with various con- 
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Chiton, Inc., Emeryville, CA). Various numbers of T cells (104, 
5  ￿  10 4,  10  5, 2  x  105, 4  x  10  s) in 0.1 ml were added to round- 
bottom wells of 96-well microtiter plates and incubated in 37~ 
CO2 for 4 h to allow for dissipation of IL-2-generated signals in 
IL-2-deprived T cells. SlCr-labeled  target cells (104 in 0.1 ml) were 
then added and after 4 h 51Cr release into culture supernatants was 
measured for triplicate samples. The percent specific  lysis was cal- 
culated relative to the total amount of 51Cr released by treatment 
with 1% NP-40, after substraction of spontaneous release from 
tumor targets incubated without T cells as described (31). In some 
cases, saturating amounts (100/xg/ml) of purified monoclonal an- 
tibodies directed against CDlla (M17) or CD18 (M18/2.a.12.7) 
were added to T cells for 15-20 rain before addition of targets at 
an E/T ratio of 10 or 20. 
Intercellular adhesion molecule 1 (ICAM-1)  Binding Assays.  A 
soluble fragment of mouse ICAM-1 representing the extracellular 
domain of the protein (slCAM-1) was produced in Chinese ham- 
ster ovary cells and purified as described previously (32). Various 
amounts of slCAM-1 or BSA control protein were incubated in 
fiat-bottom 96-well plates overnight at 4~  followed by washing 
3 x  with PBS containing 0.1 wt/vol BSA and preblocking of the 
wells with 1% BSA in PBS at 37~  for at least 2 h. RPMI medium 
(30 #1) with or without 100 nM PMA (CalBiochem-Novabiochem, 
San Diego, CA) was added to each well. CTLL-2 cell were cul- 
tured for 4 h in complete  medium containing 25 U/ml recombinant 
IL-2 and  5  #Ci/ml  [3H]thymidine, washed 3x  in  complete 
medium, resuspended at  106-107 cells/ml, and 30/zl added per 
well. Binding to slCAM-1 was allowed to proceed at 37~  for 
15 rain, after which the plates were rapidly inverted and the wells 
washed 3 x  with prewarmed medium. Adherent cells were recov- 
ered into Ecolumne scintillation fluid (ICN Chemicals, Inc., Costa 
Mesa, CA) for counting. Data are expressed as the percentage of 
cpm/well obtained for adherent cells relative to the total cpms per 
well determined from duplicate uninverted plates. 
RNA Blotting.  Total  cellular tLNA was isolated from cells and 
10/xg aliquots were size-fractionated  in 1% agarose/6% formalde- 
hyde gels and transferred to nylon membranes (Gene Screen; New 
England Nuclear/Dupont,  Inc., Boston, MA). RNA was fixed to 
filters by UV-irradiation and then prehybridized, hybridized with 
32p-labeled DNA probes, washed, and analyzed  by autoradiography 
essentially  as described previously (33). Hybridization probes con- 
sistent ofcDNAs specific  for murine perforin and granzyme A (gift 
from Ed Podack; University  of Miami, Miami, FL),  murine TNF-c~, 
LT-a, GM-CSF, IFN-'y (provided  by  James Ryan; UCSF), and mu- 
rine/~2-microglobulin (gift from Jane Parnes; UCSF). 
Immune Complex Kinase and Immunoblot Assays.  Relative  levels 
of p56-Lck kinase activity were measured in 32D-NEO and 32D- 
LCK cells by immune complex kinase assays  performed exactly as 
described previously (34) using a rabbit polyclonal antisera raised 
against a synthetic peptide (RNGSEVRDPLVTYEGSLPPAC)  cor- 
responding to residues 39-58 of the mouse p56-Lck kinase with 
a  COOH-terminal cysteine added to  facilitate conjugation  to 
maleimide-activated ovalbumin (Pierce, Rockford, IL). 
Secretion Assays.  Granule exocytosis  was monitored based on 
~-glucuronidase release into culture media essentially  as described 
by Taffs and Sitkovsky (35), with minor modifications. Briefly, 
50 #1 of CTLL-2 cells at 4  x  106 cells/ml in complete medium 
were added to round-bottom 96-well microtiter plates followed  by 
50/xl of media with or without the combination of 10 ng/ml PMA 
and 0.5/xg/ml A23187 (Calbiochem-Novabiochem).  After culturing 
for 4 h at 37~  the supernatants were recovered and as- 
sayed spectrophotometrically for/3-glucuronidase using phenol- 
phthalein glucuronic acid as the substrate. The percentage release 
of fl-glucuronidase  was calculated  relative to the total cellular con- 
tent of the enzyme obtained upon lysis with 1% Triton X-100, 
after subtraction of spontaneous background release that was com- 
parable for parental and all transfected CTLL-2 cells and always 
equaled <5% of the total cellular enzyme activity. 
Total cellular and secreted esterases were spectrophotometrically 
detected by use of the N-ot-benzyloxycarbonyl-t-lysine  thiobenzyl 
ester (BLT) substrate method (35). 
Results 
A  Model T Cell  for Studies of  Lck and Cytolytic Effector Func- 
tion.  CTLL-2 is an IL-2-dependent cytolytic  T cell line that 
was originally established in culture from C57B1/6 mice im- 
munized with allogenic tumor ceils, and that displays MHC 
nonrestricted cytolytic activity against aUogenic and syngenic 
tumor cells (26).  Previously we demonstrated that IL-2 in- 
duces rapid, transient increases in the specific activity of p56- 
Lck kinase in CTLL-2 cells, in a concentration-dependent 
manner (18). IL-2-inducible increases in the activity of the 
only other Src-like PTK present at significant levels in these 
ceils, p59-Fyn, were not detected. In an effort to explore the 
functional significance of IL-2-mediated increases in p56-Lck 
kinase activity, we stably introduced into a clone of CTLL-2 
ceils expression plasmids encoding either the normal Lck ki- 
nase (N-LCK) or a mutant version that has a tyrosine --~ phenyl- 
alanine substitution at position 505  (F505-Lck).  This mu- 
tant  form  of  Lck  removes  an  in  vivo  site  of  tyrosine 
phosphorylation that normally downregulates Lck kinase ac- 
tivity, thus locking the kinase in a constitutively active con- 
formation (A-LCK) (28). Despite (a) '~,20-fold elevations in 
the levels of p56-Lck kinase activity in both CTLL-N-LCK 
and CTLL-A-LCK cells; (b) constitutive activation of phos- 
phatidylinositol 3'-kinase  in  CTLL-A-LCK cells;  and  (c) 
striking elevations in the phosphorylation of a variety of cel- 
lular proteins on tyrosines, particularly in CTLL-A-LCK  ceils, 
these genetically modified T  calls remained completely de- 
pendent on IL-2 for their growth and survival  in culture 
(18, 19). 
In the absence of an effect of gene transfer-mediated eleva- 
tions in Lck kinase activity on the IL-2-dependent growth 
and survival of CTLL-2 cells, we next tested the cytolytic 
activity of these genetically modified T cells against a variety 
of tumor targets. Target cells were loaded with 51Cr, mixed 
with effector cells at an E/T ratio of 20,  and specific 51Cr 
release was measured in standard short-term (4-h)  cytolytic 
assays. As shown in Fig. 1, the parental CTLL-2 cells lysed 
the routine thymoma YAC-I, the human T cell acute leukemia 
lineJURKAT, and the mouse leukemia line RLcrl in an IL- 
2-dependent manner. Specific lysis of a variety of other tumor 
cells lines was not detected at significant levels (>5%) above 
background, including U937, K562, Daudi, C1498, IC-21, 
P815,  and B16F10 cells. There was no correlation between 
lysis and NK sensitivity among these target cell lines. 
Both CTLL-N-LCK and CTLL-A-LCK ceils (also referred 
to as Y505Lck and F505Lck, respectively) displayed the same 
specificity as the parental untransfected CTLL-2 ceils in these 
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Figure  1.  Analysis ofcytolytic activity of CTLb2 cells against various 
tumor target cells. Parental CTLL-2 cells (designated WT, for wild-type), 
CTLb2 cells transfected with an expression plasmid that produces normal 
p56-Lck kinase or a mutant version containing a Tyr505 ~  Phe substitu- 
tion (designated Y505-Lck and F505-Lck, respectively) were cultured with 
stCr-labeled  target cells for 4 h at an E/T ratio of 10 in the presence or 
absence of 100 U/ml recombinant Ib2 as indicated.  The percent  specific 
lysis was calculated as described (31). Data represent mean + SD for triplicate 
determinations  and  are representative  of several experiments. 
assays, inducing lysis of the same three target cell lines YAC-1, 
JURKAT, and RLcYl that were lysed by the parental CTLL-2 
cell clone but not of the seven other tumor cell lines that 
the untransfected CTLL-2 clone failed to lyse (Fig. 1). In con- 
trast to parental CTLL-2 cells, however, CTLL-N-LCK and 
CTLL-A-LCK induced lysis of a greater percentage of target 
cells (Fig.  1). Induction of lysis by these T cells that contain 
elevated levels ofp56-Lck kinase activity also was far less IL-2 
dependent than for parental CTLL-2 cells. Even in the ab- 
sence of IL-2,  CTLL-N-LCK  and CTLL-A-LCK cells ex- 
hibited cytolytic activity that was equal to or greater than 
that obtained with parental CTLL-2 cells that had been sup- 
plied with optimal concentrations of IL-2 (Fig.  1). This en- 
hanced cytolytic activity of CTLL-N-LCK and CTLL-A-LCK 
cells relative to parental CTLL-2 cells was not due to im- 
proved survival or continued cellular proliferation in the ab- 
sence of IL-2 (18). 
Characterization of the Cytolytic Activity  of Lck-transfected 
CTLL-2 Cells.  The enhanced cytolytic activity of CTLL- 
N-LCK and CTLL-A-LCK cells, relative to parental CTLL-2 
cells was apparent over a wide range of E/T ratios (Fig.  2 
A).  The lytic activity of these T  cells was also dependent 
on cell-cell contact, as determined by cold target inhibition 
studies (not shown).  Preincubation of CTLL-N-LCK and 
CTLL-A-LCK cells with the protein synthesis inhibitor cy- 
doheximide had no effect on lytic activity, implying that gene 
expression and new protein synthesis are not required for the 
killing mechanism used by these cytolytic T cells (Fig. 2 B). 
Consistent with previous investigations of mechanisms of 
CTL-induced cell death (38),  treatment of the tumor target 
cells with cycloheximide also did not impair cytolysis (not 
shown), implying that induction of new gene expression is 
also not required in the target cells. Furthermore, release of 
51Cr was preceded by prelysis  genomic DNA digestion (as 
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Characterization  of  cytolytic  effector  activity  of/ck-transfected 
CTLL-2 cells. In A, parental  WT, kk(YS05)-transfected,  and kk(F505)- 
transfected CTLL-2 cells were incubated with slCr-labeled YAC-1 targets 
for 4 h at various E/T ratios in the presence or absence of 100 U/ml recom- 
binant II.-2. The percent specific lysis was calculated and the data presented 
as mean _+ SD for triplicate determinations. In B, CTLL-N-LCK and CTLL- 
A-LCK cells were treated with (+) or without (-) 20 #g/ml cyclohexi- 
mide for 20 min in medium containing 100 U/ml recombinant  I1.-2, be- 
fore addition  of SlCr-labeled JURKAT cells at an E/T ratio of 20. slCr 
release was measured 4 h later and percent  lysis calculated (mean  _+  SD 
for triplicate  determinations).  Though representative  data for only one 
tumor target cell line are shown in each of the panels, similar results were 
obtained  with all three of the susceptible target cells (YAC-1, JURKAT, 
RLO'I) (not shown). 
determined by quantitative DNA fragmentation assays [36]), 
and  was  partially  suppressible  by  overexpression  of the 
apoptosis-blocking  oncoprotein Bcl-2 in the tumor target cells 
(36a), suggesting that an apoptotic rather than necrotic cyto- 
lyric mechanism was primarily involved (37). 
Lck  Upregulates Expression of the LFA-1  Adhesion Mole- 
cule.  Probably the first step in T  cell-mediated killing of 
target cells involves  formation of cell-cell contact through 
the interactions of specific cell surface glycoproteins. For most 
cytolytic T cells, LAK cells, and TIL cells, perhaps the most 
quantitatively important cell adhesion molecules is LFA-1 
(38-40). LFA-1 is a member of the integrin family of adhe- 
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c~- and B-chain proteins, termed CDlla and CD18, respec- 
tively (41).  LFA-1 can bind specifically  to members of the 
ICAM family of trans-plasma  membrane glycoproteins, in- 
cluding ICAM-1,  ICAM-2,  and related proteins (41). 
We therefore compared the relative cell surface levels of 
CD11a and CD18 on parental CTLL-2 cells and control trans- 
fected CTLL-2-NEO cells with CTLL-N-LCK and CTLL- 
A-LCK cells using an indirect immunofluorescence assay. As 
shown in Fig. 3 A, relative levels of both CDlla and CD18 
were markedly elevated on CTLL-N-LCK and CTLL-A-LCK 
cells. This increase in CDlla and CD18 expression was specific 
in that levels  of CD2  and VLA-4,  two other cell surface 
markers believed to play a role in the binding of T  cells to 
other cells or to the extracellular matrix (reviewed in 41) were 
not elevated on genetically modified CTLL-2 cells that con- 
tained high levels of p56-Lck kinase activity (Fig. 3 B and 
our data). In fact, levels of some plasma membrane proteins 
such as CD3 and NKI.1 were actually lower on CTLL-N- 
LCK and CTLL-A-LCK cells than on parental untransfected 
CTLL-2 cells and the control transfected CTLL-2-NEO cell 
clone (Fig. 3 B and data not shown). CD3, for example, was 
essentially undetectable on both CTLL-N-LCK and CTLL- 
A-LCK  cells.  In  addition,  NKI.1  surface  expression was 
slightly reduced on CTLL-N-LCK cells and markedly lower 
on CTLL-A-LCK cells (Fig. 3 B). Thus, high levels of p56- 
Lck kinase activity may either directly or indirectly down- 
regulated the expression of CD3 and NKI.1 on CTLL-2 cells, 
while upregulating the levels of CDlla  and CD18. 
Lck-transfected CTLL-2 Cells Exhibit Enhanced Adhesion to 
Recombinant ICAM-I.  To explore the functional status of 
LFA-1 molecules on CTLL-2 cells,  we performed binding 
assays where T cells were tested for binding to a recombinant 
protein representing the extracellular domain of the LFA-1 
ligand, ICAM-1. For these assays, the ICAM-1 fragment was 
adsorbed to wells of plastic microtiter culture plates,  and T 
cells were allowed to bind for 15 rain.  T  cells were tested 
for binding before and after activation with PMA, an agent 
known  to induce an increase in  the  affinity of LFA-1 for 
binding to its specific ligands (41, 42). Compared with pa- 
rental CTLL-2 cells, a higher percentage of both CTLL-N- 
LCK and CTLL-A-LCK cells bound to the recombinant frag- 
ment of ICAM-1 (Fig.  4). Enhanced binding was observed 
for both unstimulated and PMA-activated CTLL-N-LCK and 
CTLL-A-LCK cells. In fact, unstimulated CTLL-N-LCK and 
CTLL-A-LCK cells bound as well or better to the ICAM-1 
fragment as PMA-activated parental CTLL-2 cells. Further- 
more, upon PMA-induced activation, binding of CTLL-N- 
LCK and CTLL-A-LCK cells to the ICAM-1 fragment was 
as much as four- to sixfold higher than that obtained for pa- 
rental  CTLL-2  cells,  depending  on  the  concentration of 
ICAM-1 employed. The increased binding of CTLL-N-LCK 
and CTLL-A-LCK cells to the recombinant ICAM-1 frag- 
ment was specific, since background binding to BSA was not 
significantly higher for these cells  (Fig.  4). 
Antibodies  to  LFA-1  Abrogate  Cytolytic  Activity  of Lck- 
transfected CTLL-2 Cells.  To explore the relevance of LFA-1 
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Figure 3.  Transfected  CTLL-2  cells with increased  p56-l.ck kinase ac- 
tivity have  elevated  levels  of  LFA-1 expression.  In A, parental  CTLL-2  cells 
(control) and CTLL-2  cells that had been stably transfected  with expres- 
sion plasmids encoding either normal Lck (N-LCK)  or the Y505 mutant 
of l_ck (A-LCK)  were analyzed  by indirect immunofluorescence  assay for 
expression  of  CDlla and CD18. As an additional  control  for any nonspecific 
effects of the transfection  procedure, a CTLIr  cell clone was prepared 
that contained a neomycin-pbosphotransferase  (G418-resistance)  without 
kk sequences (NEO). Cells were incubated with saturating amounts of 
the anti-CDlla antibody  (FD4.4.1) (rat IgG2b), the anti-CD18 antibody 
(M18.5) (rat IgG2b), or a rat IgG2b negative control monoclonal  anti- 
body, followed  by FITC-conjugated  goat anti-rat IgG. Cells were ana- 
lyzed using a flow cytometer  and the data presented  as histograms with 
relative  cell number on the ordinant and relative  fluorescence  intensity  (FI) 
on the abscissa in log-scale. The mean fluorescence  channel is indicated 
for each sample. Similar data were obtained  using alternative  monoclonal 
antibodies  to CD11a (M17/4.4.11.9)  (rat  IgG2a)  and to CD18 (M18/2.a.12.7) 
(IgG2a) (not shown). In B, parental  CTLL-2  cells  (control),  CTLI~N-I.CK 
and CTLFA-LCK  cells were immunostained  for CD3, NKI.I, and CD2 
using specific  monoclonal  antibodies as described  above. FACS  |  data are 
presented as histograms, with the results for negative  control antibodies 
(isotype and subclass matched) in black and the results for monoclonal 
antibodies specific  for CD3, NKI.1, and CD2 in white. 
1119  Torigoe  et al. for  the  cytolytic effector function  of CTLL-N-LCK  and 
CTLL-A-LCK cells, we attempted to block killing by using 
monoclonal antibodies specific for CD11a.  For these experi- 
ments,  CTLL-N-LCK and CTLL-A-LCK cells were prein- 
cubated with saturating amounts of the monoclonal antibody 
M17, which recognizes a functionally important epitope on 
CD11a.  As a control for any nonspecific effects of antibody 
binding,  CTLL-N-LCK and CTLL-A-LCK cells were also 
preincubated with a monoclonal antibody M18/2.a.12.7 that 
recognizes a nonneutralizing  epitope on CD18.  As shown 
in Fig.  5 A,  anti-CDlla  antibody markedly reduced cyto- 
lytic killing of tumor target cells by both CTLL-N-LCK and 
CTLL-A-LCK cells. This effect of the antibody was largely 
specific,  since the control antibody that  recognizes a  non- 
neutralizing epitope on LFA-1 had corresponding less effect 
on cytolytic function. Furthermore, cytolytic killing was not 
blocked by the anti-NKl.1 monoclonal antibody PK136 (Fig. 
5 B), again demonstrating the specificity of the results and 
suggesting that NKI.1 is not involved in the cytolytic mech- 
anism used by CTLL-2 cells. These data thus argue that LFA-1 
plays an important role in the cytolytic mechanisms used by 
CTLL-N-LCK  and  CTLL-A-LCK  cells.  Though  murine 
LFA-1 cannot recognize human ICAM-1 (43), the anti-LFA-1 
antibody M17 did inhibit lysis of human JURKAT cells in- 
duced by CTLL-N-LCK and CTLL-A-LCK cells (not shown). 
Thus, routine LFA-1 may mediate binding of CTLL-2 cells 
to this human leukemic line via interactions with other iso- 
forms of ICAM,  such as ICAM-2  or ICAM-3/ICAM-R. 
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Figure 4.  CTLL-2  cells with gene transfer-mediated elevations  in p56- 
Lck kinase activity exhibit enhanced binding to a recombinant fragment 
of ICAM-1. Various amounts of purified recombinant protein (0-500 ng) 
representing a soluble fragment from the extracellular  domain of ICAM-1 
(slCAM-1) or 500 ng of  BSA were absorbed to plastic microwells. Parental 
CTLI~2 cells (C), CTLL-N-LCK or CTLL-A-LCK  cells were metaboli- 
cally labeled with [3H]thymidine, washed, and incubated in slCAM- or 
BSA-containing wells for 15 min in the presence (solid bars) or absence 
(hatched bars) of PMA. Nonadherent cells were removed  and the percentage 
of adherent cells calculated  as follows:  percent adherent cells = [cpm from 
bound cells/(cpm from total input cells)] x  100. Data represent mean 
_+  SD for three determinations. 
Figure 5.  Anti-CDlla monoclonal  antibody blocks cytolytic  killing by 
kk-transfected cells. In (.4), CTLL-2  cells that had been stably transfected 
with expression  plasmids encoding normal Lck kinase (Y505Lck) or acti- 
vated Lck containing a Tyr505 -* Phe substitution (F505Lck) were in- 
cubated with either no antibody (control) or 100 #g/ml of a neutralizing 
anti-CD11a antibody M17/4.4.11.9 (rat IgG2a) or a nonneutralizing anti- 
CD18 antibody M18/2.a.12.7 (rat IgG2a). StCr-labeled RLo'I cells were 
then added at an E/T ratio of 10 and specific  slCr release was measured 
4 h later. Data represent mean _+ SD for three determinations. In (B), 
parental CTLL-2  cells (C), kk-transfected  CTLL-2  (N-LCK), and kk (Y505)- 
transfected CTLL-2 cells (A-I.CK) cells were incubated briefly with (+) 
or without (-) 10 #g/ml purified anti-NKl.1 antibody PK136 and then 
slCr release was measured from JURKAT target cells 4 h later and the 
percent specific  lysis (_+ SD) determined  for triplicate samples. Similar  data 
were obtained  when RLo'I cells were employed  as the target (not shown). 
Elevations in Lck Kinase Activity also Upregulate LFA-1 Ex- 
pression  in  32D3  Cells.  As  a  first  attempt  to  determine 
whether elevations in LFA-1 expression were a general char- 
acteristic of cells that contain high levels of p56-Lck kinase 
activity versus a feature specific to CTLL-2 cells, we also stably 
introduced an expression plasmid encoding the p56-Lck(FS05) 
protein into an IL-3-dependent myeloid cell clone, 32.D.3 
(27).  As  a control,  the  same expression vector lacking kk 
sequences was stably introduced into 32D.3 cells, thus creating 
the line 32D-NEO.  In vitro immune complex kinase assays 
confirmed the presence of markedly elevated levels of p56- 
Lck kinase activity in 32D-LCK(F505) cells relative to 32D- 
1120  p56-Lck  Regulates Cytotoxic T Cell Effector Function NEO cells (Fig. 6 A). FACS  |  analysis of cells immunostained 
with antibodies specific for CDlla or CD18 revealed increased 
levels of both CDlla and CD18 on 32D-LCK(Y505F) cells 
relative to 32D-NEO (Fig. 6 B). These findings thus argue 
that the ability of p56-Lck to stimulate elevations in LFA-1 
expression  is not limited to CTLL-2 cells. 
Lck Does Not Cause Constitutive Elevations in the Expression 
of Several Genes Associated with Cytolytic Killing.  The obser- 
vation that CTLL-2 cells which have gene transfer-mediated 
elevations  in Lck kinase activity are more potent at killing 
target cells prompted us to examine the expression  of a va- 
riety of genes whose encoded proteins have been associated 
either directly or indirectly with induction of cell death by 
CTLs. Furthermore, the finding that protein synthesis is not 
required for cytolytic killing by CTLL-N-LCK and CTLL- 
A-LCK cells (Fig. 2 B) argued that if increases in the expres- 
sion of other genes were important, then the expression  of 
these genes would have to be constitutively elevated as op- 
posed to becoming activated after binding of T cells to specific 
target cells. In addition, since CTLL-N-LCK and CTLL-A- 
LCK cells kill in a far less IL-2-dependent manner than pa- 
rental CTLL-2 cells, it was possible that genes whose expres- 
sion was normally IL-2 inducible would be expressed in an 
IL-2-independent fashion in CTLL-N-LCK and CTLL-A- 
LCK cells. Relative levels of mRNAs were therefore com- 
pared in T  cells that had been deprived of IL-2 for 4 h in 
an effort to detect any Lck-mediated alterations in gene ex- 
pression that might account for the superior cytolytic  activity 
of the CTLL-N-LCK and CTLL-A-LCK  cells relative to pa- 
rental CTLL-2 cells. 
As shown in Fig. 7 A, no constitutive elevations  in the 
levels of mRNAs encoding TNF-oe, LT-c~, or IFN-3' were 
detected in CTLL-N-LCK  and CTLL-A-LCK  cells. 1Lelative 
levels of GM-CSF mRNA, a gene whose expression  is IL-2 
inducible (44), were also not constitutively increased in CTLL- 
N-LCK and CTLL-A-LCK cells despite their high levels of 
p56-Lck kinase activity. Stimulation of  parental CTLL-2 cells 
with either IL-2 or the combination of the Ca  2§  ionophore 
ionomycin and PMA served  as a positive control for these 
Northern blot  assays, inducing the accumulation of lym- 
phokine mRNAs to easily detectable levels (Fig.  7 A). 
It is interesting to note that steady-state levels of mRNAs 
for perforin, a protein with homology to the C9 component 
of complement (45), and granzyme A, a serine protease (46), 
were markedly reduced in CTLL-N-LCK and CTLL-A-LCK 
cells relative to parental CTLL-2 cells. Thus, CTLL-2 cells 
genetically modified to have increased  levels of p56-Lck ki- 
nase activity are able to kill ef~ciently despite reductions in 
the relative amounts of expression of these two genes whose 
encoded proteins are stored in the cytotoxic granules of T 
cells and have been implicated directly in cytolytic effector 
mechanisms (47). 
Another cell death-inducing protein that is stored in the 
cytotoxic granules of killer T cells is the RNA-binding pro- 
tein apoptosin, also known as nucleolysin and T cell intracel- 
lular antigen (TIA) (48). Since antibodies that recognize the 
mouse form of TIA-1 have not been described  to date, pa- 
rental and transfected CTLL-2 cells were examined for ex- 
pression of TIA-1 by Northern blot assay  using a mouse TIA-1 
cDNA hybridization probe (generously provided by Mark 
Boothby;  Vanderbilt  University,  Nashville,  TN).  TIA-1 
mRNA  however was only barely perceptible,  even when 
polyadenylate-selected mRNA was employed (not shown). 
Reverse transcriptase-PCR  analysis  under semiquantitative con- 
ditions confirmed the presence of at least low levels of TIA-1 
mRNA in parental and transfected CTLL-2 cells but no con- 
sistent difference in the relative levels of TIA-1 mRNA was 
detected between untransfected CTLL-2 cells and the trans- 
Figure 6.  Production  of activated  p56-I.ck(Y505F) 
kinase in 32D,3 cells upregulates LFA-1 expression. 
The IL-3-dependent  myeloid  clone 32D.3 was stably 
transfected  with either  pLXSN  or pLXSN-kk(YSOSF) 
plasmids and the resulting G418-resistant cells were 
analyzed  for production  of p56-Lck  kinase  activity  (.4) 
and expression  of LFA-1 (/3). In A, 1% NP-40 lysates 
were prepared from 2  x  106 cells and subjected to 
immunoprecipitation  using an antiserum  specific  for 
p56-Lck. Immune  complexes  were incubated  with a 
kinase reaction  buffer  containing  "y-[32p]ATP  and the 
exogenous substrate enolase  (E). The reaction  prod- 
ucts were  analyzed  by SDS-PAGE  followed  by autora- 
diography. (Data shown  represent a 5-min exposure 
to X-ray film). An unidentified  additional copre- 
cipitating  band  was routinely  observed  in Lck immune 
complex  kinase  assays  performed  using  3213.3 cells  (open 
arrow) but not other cells (not shown). In B, 32D.3 
cells containing  either pLXSN (NEO) or pLXSN- 
kk(YS05F) [Lck(Y505F)] were analyzed  for surface 
expression of CDlla  and CD18 by indirect im- 
munofluorescence  assay  with flow  cytometric  analysis 
as described  for Fig. 4. Results  for 32D-NEO and 3219- 
Lck(Y505F) cells are presented  as shaded  and unshaded 
histograms, respectively. 
1121  Torigoe  et al. Figure  7.  Analysis  of expression of various mediators  of CTbinduced 
cell death  in CTLL-2  cells. In A, parental  CTLL-2  cells  (lanes 1-3), CTLb 
N-LCK cells (lane 4), and CTLDA-LCK  cells (lane 5) were stripped of 
11:2 and rested for 4 h. Cells were then restimulated  for 2 h with 100 
U/ml recombinant  11:2 (lane 2), or 0.5/xM ionomycin  and 100 ng/ml 
PMA (lane 3). Total  cellular  RNA was isolated  and 10/~g aliquots ana- 
lyzed  by Northern  blotting  using  probes specific  for murine  perforin,  gran- 
zyme  A, TNF-c~, LT-c~,  INF-'y, GM-CSF, and Bz-microglobulin  (/~2M). 
The 2-h stimulation  time was empirically  determined  to be optimal for 
induction of all cytokine  mRNAs in CTL1:2  cells (data not shown). The 
positions  of selected  molecular  weight  markers  (RNA ladder  BRL-GIBCO) 
are indicated. In B, untransfected  CTLD2 and CTL1:A-LCK  cells were 
cultured for 2 d with or without 11:2 or the combination  of PMA and 
A23187 and then incubated  with TNF-R/Fc fusion  protein followed  by 
fluorescein-conjugated  goat anti-human  IgG antibody.  Relative  levels of 
immunofluorescence  were measured  by FACS  |  analysis  and the data dis- 
played  as histograms  with relative  cell number (y-axis)  vs. relative  fluores- 
cence intensity  (FI) in log-scale (x-axis). 
fected CTLL-N-LCK and CTLL-A-LCK cells, regardless of 
whether the cells were quiescent versus stimulated with IL-2 
or with Ca  2+-ionophore and PMA (our unpublished obser- 
vations). 
In addition to cytotoxic proteins stored in secretory granules 
(TIA-1, proteases, perforins) and expression of genes encoding 
cytotoxic lymphokines (TNF-ot, LT-c~), signals for cell death 
can be delivered during cell-cell contact by receptor-ligand 
interactions that occur at the plasma membrane (49). We also 
therefore examined the cell surface levels of TNF-ot, Fas-ligand, 
CD27-1igand, and CD30-1igand on parental and genetically 
modified CTLL-2 cells by indirect immunofluorescence assays, 
using recombinant chimeric proteins consisting of the ex- 
tracellular domains of TNF-ot, Fas, CD27, or CD30 fused 
with an immunoglobulin Fc region generously provided by 
Drs. Craig Smith and Ray Goodwin oflmmunex, Inc. (Seattle, 
WA) and Carl Ware of University of California (Riverside, 
CA). Cell surface expression of TNF-ot was present at levels 
slightly above background but was not appreciably  elevated 
on CTLL-N-LCK and CTLL-A-LCK cells relative  to con- 
trol CTLL-2 cells, regardless of whether or not the cells were 
stimulated with IL-2 or the combination of PMA and Ca  2+- 
ionophore.  Stimulation  with  PMA  and  Ca2+-ionophore 
however did induce an increase  in cell surface TNF-c~ but 
the relative  levels of immunofluorescence were not higher 
for CTLL-A-LCK  cells than control CTLL-2 cells and in fact 
tended to be somewhat lower (Fig. 7 B). FACS  |  analysis of 
the ligands for Fas, CD27, and CD30 produced levels of im- 
munofluorescence  that were not detectably above background 
on parental and genetically modified CTLL-2 cells even after 
stimulation with IL-2 or with PMA and Ca  2§  ionophore 
(not shown). Thus, while it is possible that TNF-ot or LT-ot 
may participate in the cytotoxic mechanism by which CTLL- 
N-LCK  and  CTLL-A-LCK  cells  kill  target  cells,  p56- 
Lck-mediated alterations in the expression of these genes do 
not appear  to account for the superior cytolytic activity of 
CTLL-2 cells that contain gene transfer-mediated elevations 
in Lck kinase activity. 
Lck Enhances Activation-induced Secretion by CTLL-2 Cells. 
During T cell-mediated cytolytic  killing, granules are released 
by the T cells through an exocytosis process, thus delivering 
perforins, proteases,  apoptosins, Ca  2+,  ATP, and probably 
other potentially cytotoxic substances to the target cell. Also 
contained within these granules is ~-glucuronidase, an en- 
zyme whose activity can be measured by a simple colorimetric 
assay (50). 
To determine whether Lck influences the process of granule 
exocytosis,  parental CTLL-2 cells, as well as control trans- 
fected CTLL-NEO cells, and the CTLL-N-LCK and CTLL- 
A-LCK cells were cultured for 4 h in the presence or absence 
of PMA and the Ca  2  +-ionophore, A23187.  The combina- 
tion of PMA and A23187 is known to trigger granule exocy- 
tosis in a process that recapitulates  many of the biochemical 
events that occur during normal T cell activation (35). Both 
parental and genetically modified CTLL-2 cells displayed very 
little spontaneous secretion of/3-glucuronidase regardless of 
their levels of Lck kinase activity. Activation-induced secre- 
tion, however, was much higher (~7-14-fold) for CTLL-A- 
LCK cells which contain the activated Tyr505 --~ Phe version 
of Lck kinase, compared with parental CTLL-2 and CTLL- 
NEO cells (Table 1). CTLL-N-LCK  cells, which overproduce 
normal Lck kinase,  secreted  at levels intermediate to those 
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Experiment  1  Experiment  2  Experiment  3 
~-glucuronidase 
Percent  Total  Percent  Total  Percent  Total 
CTLL-2  0  _+  0.6 
CTLL-NEO  1.6  _+  1.0 
CTLL-N-LCK  12.1  _+  1.2 
CTLL-A-LCK  28.5  _+  0.8 
0.63  _+  0.02  0.8  _+  0.4  0.39  _+  0.01  1.4  _+  0.3  0.18  _+  0.0 
0.49  _+  0.01  2.6  _+  0.3  0.36  +  0.01  3.7  _+  0.0  0.13  _+  0.02 
0.39  _+ 0.03  11.2  _+  1.0  0.24  _+  0.07  16.8  _+  3.1  0.13  _+  0.0 
0.39  _+  0.01  19.7  _+  10.5  0.19  _+  0.0  42.0  +_  1.7  0.16  _+  0.01 
BLT-esterase 
Total  Secreted  Total  Secreted  Total  Secreted 
CTLL-2  0.004  -+ 0.004  0.137  +  0.036  0  -+ 0  0.631  -+ 0.068  0.008  -+ 0.01  0.409  +- 0.034 
CTLL-NEO  ND  ND  ND  ND  0.002  _+  0.002  0.245  -+  0.025 
CTLL-N-LCK  0.004  _+  0.001  0.006  +_  0.007  0  +_  0  0.004  _+  0.004  0  -+ 0  0  -+ 0 
CTLL-A-LCK  0.003  _+  0.002  0.004  _+  0.002  0  _+  0  0  +_  0  ND  ND 
CTLL-2, CTLL-NEO, CTL-N-LCK, and CTLL-LCK ceils were cultured for 4 h in medium with or without the combination of PMA and A23187. 
Culture supernatants were then assayed for relative levels of/3-glucuronidase or BLT esterase enzyme activities (mean _+ SD; n =  3). Total cellular 
associated B-glucuronidase and BLT esterase enzyme activity was also measured using cell lysates prepared from an equal number of unstimulated 
cells. In the top half, the percent of cellular/3-glucuronidase activity released into culture supernatants was calculated, after subtraction of spontaneous 
release that occurred in the absence of stimulation with PMA and A23187 (always ~<5% of total cellular 3-glucuronidase). The total cellular levels 
of/3-glucuronidase were also compared among control and transfected CTLL-2 cells and the data expressed as OD 550 nm units.  In the bottom 
half, relative amounts of secreted and total BLT esterase activity were measured and the data expressed as OD 412 nm units. Secreted BLT esterase 
activity represents the difference between  PMA and A23187-induced and spontaneous released. Spontaneous BLT esterase release was comparable 
for all cell lines (not  shown). 
observed for CTLL-A-LCK and parental CTLL-2 cells (Table 
1). The increased levels of/~-glucuronidase release from CTLL-2 
cells that contained elevated levels of p56-Lck kinase activity 
was not due to induction  of cell lysis by PMA and A23187, 
since >95%  of cells continued  to exclude  trypan blue dye 
at  the  end  of the  4-h  assay (not  shown). 
Though CTLL-N-LCK and CTLL-A-LCK cells released 
more 3-glucuronidase into the medium than parental CTLL-2 
and CTLL-NEO cells after stimulation, the total cellular levels 
of this enzyme were not higher in CTLL-2 cells that contain 
gene transfer-mediated elevations in Lck kinase activity com- 
pared to control cells (Table 1). Also, the approximate number 
and size of granules was not increased in CTLL-A-LCK cells 
relative to parental CTLL-2 cells, based on conventional light 
and electron microscopic analyses (our unpublished observa- 
tions).  Thus,  high levels of p56-Lck kinase activity are as- 
sociated with  a marked increase in the efficiency or rate of 
activation-induced  exocytosis rather  than  due  to elevations 
in the size of the cytotoxic granule pool. Though increased 
levels of p56-Lck kinase activity clearly enhanced exocytosis 
induced by PMA and Ca  2 +-ionophore, we have been unable 
to confirm these  results  using  tumor  targets  cells in  place 
of pharmacological T  cell activating  agents, because of the 
complication of/~-glucuronidase release from dying targets. 
In contrast to/~-glucuronidase,  CTLL-2 cells did not se- 
crete N-c~-benzyloxycarbonyl-L-lysine thiobenzyl ester (BLT) 
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esterases after stimulation  with PMA and A23187.  In fact, 
lysates prepared from parental and genetically modified CTLL-2 
cells contained little BLT esterase activity,  suggesting  that 
these cells are relatively deficient in this class of enzymes com- 
monly used as a measure of degranulation of CTLs (Table 1). 
Discussion 
Increases in the specific activity of the p56-Lck kinase can 
be induced  in lymphocytes via a  number  of plasma mem- 
brane  receptors  whose  cytoplasmic  domains  can  interact 
directly or indirectly with this PTK, including CD4, CD8, 
CD16,  and the/5-chain of the IL-2 receptor complex (2-6). 
Here we used gene transfer approaches to explore the func- 
tion of Lck in an IL-2-dependent cytolytic T  cell clone de- 
rived from the CTLL-2 cell line. Gene transfer-mediated ele- 
vations  in  the  levels  of p56-Lck  kinase  activity  markedly 
enhanced the cytolytic effector function of these T cells (Figs. 
1 and 2) without altering their dependence on IL-2 for growth 
and  survival  in  culture  (18),  The  events  involved in  CTL 
effector function can be divided into at least four discrete steps: 
(a) binding  of T  cells to target cells;  (b) triggering  of the 
T  cells through appropriate receptors to induce a variety of 
intracellular biochemical events broadly termed T  cell "acti- 
vation"; (c) exocytosis of granules that release toxic proteins 
and other substances onto the surface of the target cell; and in some cases (d) delivery of additional cell death signals  to 
the target cell via membrane-associated or secreted cytokines 
and other proteins such as Fas-ligand (reviewed in 49).  Lck 
appears  to regulate at least two of these four steps: binding 
and exocytosis. 
Both  CTLL-2  and  32D.3  cells  that  contained  gene 
transfer-mediated elevations in Lck kinase activity displayed 
higher  surface  levels  of CDlla  and  CD18,  the  ~-  and 
3-subunits of the 32 integrin LFA-1. The affinity of LFA-1 
for its ICAM counter-receptors becomes strikingly increased 
upon T cell activation through a poorly understood mecha- 
nism that appears to depend on protein kinase C  and that 
can be emulated by stimulation of LFA-l-expressing cells with 
the phorbol esters such as PMA (41, 42). Thus, LFA-1 can 
potentially participate in two phases of the cell adhesion pro- 
cess involved in CTL function. First,  low-affinity binding 
of LFA-1  to its receptors may help to increase the time of 
interaction between effector and target, thus allowing for trig- 
gering of other receptors on the T cell that can generate signals 
for T cell activation (e.g., TCR with MHC-class I/antigen). 
After T  cell activation,  LFA-1  then mediates high-affinity 
binding of T cell and target, an event that also indirectly facili- 
tates TCR interaction with MHC/antigen in many cases, and 
thus potentiates  the TCR-mediated activation process.  In 
CTLL-2 ceils, gene transfer-mediated elevations in p56-Lck 
kinase activity increased both constitutive and PMA-induced 
binding of these T ceils to a recombinant fragment of ICAM-1 
(Fig.  4),  suggesting  that  the elevated levels of LFA-1  on 
CTLL-2 cells may enhance both pre- and postactivation adhe- 
sion to tumor target cells, Though it remains to be deter- 
mined whether a general role for Src-like kinases in the regu- 
lation of cell adhesion will be found, we have also observed 
elevations in LFA-1 expression in Lyn-transfected myeloid cell 
lines (Torigoe, T., J. Millan, and J. C. Reed, manuscript in 
preparation), which are known to undergo specific elevations 
in their levels of Lyn kinase activity in response to IL-3 and 
GM-CSF  (51). 
In  addition  to  upregulation of LFA-1  expression,  gene 
transfer-mediated elevations in Lck kinase activity resulted 
in markedly enhanced granule secretion by CTLL-2 cells. Pre- 
viously, pp60-c-Src has been implicated in the regulation of 
exocytosis in bovine chromafhn cells,  where it is found in 
association not only with the plasma membrane but also with 
the membranes of chroma~n granules which contain nor- 
epinephrine and other secretory products (52, 53). Further- 
more, pp60-c-Src has been found in direct association with 
synaptophysin, and can induce phosphorylation of this 38-kD 
protein which is a major constituent of synaptic vesicles and 
is thought to play a critical role in the exocytosis of synaptic 
vesicles in neuroendocrine cells (54).  In CTLL-2 cells, secre- 
tion of/3-glucuronidase, a lysosomal protein that is stored 
in the cytotoxic granules of cytolytic T  cells (50),  did not 
occur constitutively but  rather required activation signals 
which could be provided by the combination of PMA and 
A23187 (Table  1). Lck appeared to potentiate those signals 
for exocytosis of granules, with the constitutively activated 
F505 version of Lck having greater effect than over-production 
of normal Lck kinase.  It remains to be determined whether 
I.ck directly regulates degranulation in cytolytic T  cells by 
analogy to pp60-c-Src that associates with and phosphory- 
lates proteins associated  with secretory vesicles in neuroen- 
docrine cells. 
Within the cytotoxic granules of CTLs are at least three 
substances that have been reported to induce rapid DNA frag- 
mentation and apoptosis in target cells: TIA-1, proteases, and 
ATP. Both TIA-1 and proteases require perforin or perforin- 
like proteins to gain access to the cytosol of target cells and 
thus exert their cell death-inducing effects. ATP, in contrast, 
can  exert  its  effect extracellularly, perhaps  via purinergic 
receptors or ectokinases (55). Though perforin mRNA levels 
were very low in CTLL-N-LCK and CTLL-A-LCK cells, 
it is possible  that enough perforin is made by these T  cells 
to provide at least  a transient passage  through the plasma 
membrane of target cells for entry of TIA-1 or pro teases (56). 
Similarly, though granzyme A mRNA was undetectable in 
CTLL-N-LCK and CTLL-A-LCK cells and BLT esterase ac- 
tivity was very low in these cells, granzyme A represents only 
one of many different serine proteases that can be present 
within the granules of CTLs and the BLT esterase assay does 
not detect some classes of proteases such as cysteine proteases 
(57). Thus, a perforin- or protease-dependent mechanism for 
induction of cell death cannot be excluded from the data avail- 
able thus far. Alternatively, the CTLL-2 cells may use mech- 
anisms for induction of cell death that do not depend on in- 
jection of molecules across the plasma membrane of the target 
cell,  such as those involving ATP release or interactions of 
plasma membrane-associated TNF-a, LT, and Fas-ligand with 
their specific receptors on target cells. Preliminary attempts 
to block the cytolytic function of parental and Ick-transfected 
CTLL-2 cells using neutralizing anti-TNF-o~ antibodies how- 
ever have been unsuccessful (our unpublished observations). 
We have also found that kk-transfected CTLL-2 cells do not 
lyse the TNF-sensitive target, WEHI-164 (our unpublished 
observations). Whatever the cell death mechanism used by 
CTLL-2 cells to induce target cell lysis, our findings are in 
agreement with those of other investigators who have noted 
a lack of correlation between cytolytic activity and the per- 
forin and BLT esterase content of T cells and their granules 
(39,  58,  59). 
Analysis of CTLL-N-LCK and CTLL-A-LCK cells revealed 
reduced levels of granzyme A  mRNA relative to parental 
CTLL-2 cells,  suggesting that p56-Lck downregulates ex- 
pression of this serine protease-encoding gene. Velotti et al. 
(60) previously demonstrated that interaction of target cells 
with NK cell and LAK cells induces transient decreases in 
granzyme A mRNA levels. Thus, if p56-Lck kinase activa- 
tion occurs during the stimulation of NK and LAK cells by 
appropriate target cells,  it could be that p56-I.ck regulates 
a negative feedback loop that involves downmodulation of 
granzyme A. We cannot exclude the possibility however that 
the reductions in granzyme A, as well as those in CD3 and 
NKI.1, seen in/ck-transfected CTLL-2 reflect a selection pro- 
cess as opposed to direct downregulation by a p56-Lck-de- 
pendent signal transduction pathway. For example, the ex- 
1124  p56-Lck  Regulates Cytotoxic T Cell Effector  Function pression of CD3, NKI.1, and granzyme A could somehow 
be detrimental to the growth or survival of T cells that have 
constitutively high levels p56-Lck kinase activity. In this re- 
gard, cross-linking of CD4 on the surface of T cells (a proce- 
dure known to transiently activate p56-Lck [2]) prior to stim- 
ulation through  CD3 has been shown to induce apoptosis 
of T cells (61),  suggesting that constitutively high levels of 
p56-Lck kinase activity could be deleterious for CD3-bearing 
T  cells. 
The receptor(s) used by CTLL-2 cells for target cell recog- 
nition and triggering of T cell activation and exocytosis are 
unknown.  Though  cytolytic killing  by CTLL-2  cells  was 
clearly not MHC restricted,  there was a specificity to the killing 
in that  only 3 of 10 tumor lines were effective targets  for 
these T  ceils.  It seems unlikely that  either CD3 or NKI.1 
are involved in this process, since Lck gene transfer markedly 
downregulated the expression of these cell surface antigens 
that are known to be capable of mediating cytolytic killing 
in antibody-redirected cytolysis assays. Consistent with pre- 
vious studies of LFA-1/ICAM-1  interactions  (41),  the ex- 
pression of ICAMs on the surface of the target  cell is also 
insufficient for triggering  cytolysis by CTLL-2 cells,  since 
FACS  |  analysis demonstrated high relative levels of ICAM-1 
on the surface of some tumor cell lines which CTLL-2 cells 
failed  to lyse (our unpublished  observations).  Though  the 
specific recognition receptors involved are unknown,  prob- 
ably the cytolytic activity of parental and genetically modified 
CTLL-2 cells can be enlikened to that of LAK cells, which 
are functionally characterized by their ability to lyse a variety 
of NK-sensitive and -resistant tumor cell targets in an MHC- 
nonrestricted fashion (62). Consistent with this notion, the 
original report of CTLL-2 ceils described cytolytic activity 
against both syngenic and allogenic tumor cells  (26).  The 
presence of both a classical T cell marker CD3 and the NK 
cell marker NKI.1 on parental CTLL-2 cells is also reminis- 
cent of LAK cells, since immunophenotypic analysis of these 
ceils has sometimes revealed subpopulations of cells that ex- 
press combinations  of T  cell and NK cell markers  (63). 
Recent investigations of lymphocytes recovered from the 
spleens of animals that bear solid tumors have demonstrated 
a decrease in the relative levels of p56-Lck and some other 
signal transducing proteins, suggesting that tumor-induced 
defects in T  cell signal transduction pathways may provide 
an explanation  for the failure of the immune system to re- 
spond to and eliminate cancer cells in many cases (24). Simi- 
larly,  reduced levels of p56-Lck as well as the TCR-~" chain 
have been described in the TILs of patients with renal carci- 
noma (25). The findings presented here which link p56-Lck 
to the regulation of specific events involved in cytolytic effector 
function may therefore provide additional insights into the 
molecular mechanisms of tolerance induction by tumors. Fur- 
ther in vitro and in vivo studies are required however to assess 
the overall  significance of p56-Lck in the complex series of 
molecular and cellular events that determine the outcome of 
host immune  responses to tumors. 
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